Title : Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.

Pub. Date : 2004 Jun

PMID : 32585787






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nicotinic cholinergic receptor (nAChR) sites that bind nicotine with high affinity (likely alpha4beta2-nAChR) increase following chronic nicotine treatment. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
2 Nicotinic cholinergic receptor (nAChR) sites that bind nicotine with high affinity (likely alpha4beta2-nAChR) increase following chronic nicotine treatment. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
3 Nicotinic cholinergic receptor (nAChR) sites that bind nicotine with high affinity (likely alpha4beta2-nAChR) increase following chronic nicotine treatment. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
4 Nicotinic cholinergic receptor (nAChR) sites that bind nicotine with high affinity (likely alpha4beta2-nAChR) increase following chronic nicotine treatment. Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus
5 As anticipated, likely alpha4beta2-nAChR [125I]-epibatidine binding sites increased with treatment (estimated dosage for one-half maximal increase was 0.44 mg/kg/h, plasma nicotine 20 ng/ml). Nicotine cholinergic receptor, nicotinic, alpha polypeptide 7 Mus musculus